NanoMug technology
NanoMugs are multifunctional nanoparticles, intrinsically glycosylated, mucoadhesive and able to incorporate drugs.
The one pot synthesis method allows to obtain completely functional nanoparticles within approximately 12 hours (lab scale).
In one single product NanoMugs enclose a triple effect:
New strategies
to fight pathogens
Infectious disease represents a stubborn and major public-health problem all over the world. To worsen the situation is the spreading of antimicrobial resistance which hamper the effective prevention and treatment of a wide range of infections.
It is estimated that deaths and costs due to infectious diseases will continue to rise in the coming decades.
The most effective defensive line against infectious diseases resides in vaccination. However, this option is not always available, and the development of a new vaccine requires an enormous amount of time and money.
We need new strategies to fight pathogens and better ways to efficiently deliver new or existing drugs.
Advantages
Biologically relevant
No toxicity
Biocompatible
Mucoadhesion
Adherence to mucus
Targeting
glycans-mediated pathogens engagement
Drug repositioning
encapsulation of new or existing drugs
Production
One pot synthesis
easy to produce
Stability
Lyophilized powder
Scalable synthesis
Scalable production method
Low cost
Lab scale
Killer application
We offer a minimum viable product that can initially be thought of as a product that can be used by inhalation. But we can heal further.
Thanks to the presence of carbohydrates, NanoMug can also have an application in the antitumor and immune fields.
This aspect makes NanoMug a “cross product”, usable in different medical treatments.
For these reasons, the NanoMugs could be interesting for potential investors who find in a single product the possibility of ranging in multiple therapeutic fields.
Market
The reference market and the competitive landscape of NanoMug is that of drug delivery systems for example for inhalatory and pulmonary applications.
Within a market with a growth rate of approx. 5%, a product with NanoMug characteristics would allow a clear positioning of the technology as an innovative synergy between nano systems and glycomimetic drugs.
Furthermore, based on a benchmark with the principal competitors and protein-based nano systems on the market, NanoMug can have incomparable advantages in terms of cost.
Possible applications
Drug delivery to counteract bacterial and viral infectious diseases
Drug repositioning of existing drugs for new therapeutic purposes
Molecular imaging
Vaccines